Senior insider sale
Chief Financial Officer at VOR BIOPHARMA INC. — senior position signals high conviction
$28.7K
30.10K shares
What this filing means
JORGENSEN NATHAN D. plans to sell 30.10K shares of VOR BIOPHARMA INC. valued at approximately $28.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/19/2024ACC: 0001842523-24-000001
Officer· Chief Financial Officer
Since Feb 2021
30.10K
Shares to sell
$28.7K
Approx. market value
29.27K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Private Placement Tranche
NA
1/8/2021
1.77KPrivate Placement Tranche
NA
10/29/2020
1.77KExercise of options under a registered plan
NA
6/30/2020
25.73KTotal acquired29.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/8/2021 | Private Placement Tranche NA | 1.77K | — |
10/29/2020 | Private Placement Tranche NA | 1.77K | — |
6/30/2020 | Exercise of options under a registered plan NA | 25.73K | — |
| Total | 29.27K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
834.00
Market value
$1.5K
5/6/2024
Planned — Approximate Date
VORPlanned
Units to sell
29.27K
Market value
$27.2K
7/3/2024
Total
Units
30.10K
Value
$28.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/6/2024 | 834.00 | $1.5K | — | Completed |
| Planned — Approximate Date | ||||
7/3/2024 | 29.27K | $27.2K | VOR | Planned |
| Total | 30.10K | $28.7K | ||